{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:04:47Z","timestamp":1792411487016,"version":"4.4.0"},"reference-count":81,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES<\/jats:title>\n                  <jats:p>Geographic accessibility predicts pediatric preventive care utilization, including vaccine uptake. However, spatial inequities in the pediatric coronavirus disease 2019 (COVID-19) vaccination rollout remain underexplored. We assessed the spatial accessibility of vaccination sites and analyzed predictors of vaccine uptake.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>In this cross-sectional study of pediatric COVID-19 vaccinations from the US Vaccine Tracking System as of July 29, 2022, we described spatial accessibility by geocoding vaccination sites, measuring travel times from each Census tract population center to the nearest site, and weighting tracts by their population demographics to obtain nationally representative estimates. We used quasi-Poisson regressions to calculate incidence rate ratios, comparing vaccine uptake between counties with highest and lowest quartile Social Vulnerability Index scores: socioeconomic status (SES), household composition and disability (HCD), minority status and language (MSL), and housing type and transportation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We analyzed 15\u2009233\u2009956 doses administered across 27\u2009526 sites. Rural, uninsured, white, and Native American populations experienced longer travel times to the nearest site than urban, insured, Hispanic, Black, and Asian American populations. Overall Social Vulnerability Index, SES, and HCD were associated with decreased vaccine uptake among children aged 6 months to 4 years (overall: incidence rate ratio 0.70 [95% confidence interval 0.60\u20130.81]; SES: 0.66 [0.58\u20130.75]; HCD: 0.38 [0.33\u20130.44]) and 5 years to 11 years (overall: 0.85 [0.77\u20130.95]; SES: 0.71 [0.65\u20130.78]; HCD: 0.67 [0.61\u20130.74]), whereas social vulnerability by MSL was associated with increased uptake (6 months\u20134 years: 5.16 [3.59\u20137.42]; 5 years\u201311 years: 1.73 [1.44\u20132.08]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Pediatric COVID-19 vaccine uptake and accessibility differed by race, rurality, and social vulnerability. National supply data, spatial accessibility measurement, and place-based vulnerability indices can be applied throughout public health resource allocation, surveillance, and research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2024-065938","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T14:38:23Z","timestamp":1721399903000},"source":"Crossref","is-referenced-by-count":11,"title":["Spatial Accessibility and Uptake of Pediatric COVID-19 Vaccinations by Social Vulnerability"],"prefix":"10.1542","volume":"154","author":[{"given":"Rohan","family":"Khazanchi","sequence":"first","affiliation":[{"name":"aHarvard Internal Medicine-Pediatrics Residency Program at Brigham and Women\u2019s Hospital, Boston Children\u2019s Hospital, and Boston Medical Center, Boston, Massachusetts"},{"name":"bDepartments of Internal Medicine"},{"name":"cPediatrics"},{"name":"eFXB Center for Health and Human Rights, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rader","sequence":"additional","affiliation":[{"name":"fComputational Epidemiology Laboratory, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"gDepartment of Anesthesiology, Critical Care, and Pain Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cantor","sequence":"additional","affiliation":[{"name":"hRAND Corporation, Santa Monica, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"McManus","sequence":"additional","affiliation":[{"name":"iDivision of Infectious Diseases and International Health, Department of Internal Medicine, University of Virginia, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena M.","family":"Bravata","sequence":"additional","affiliation":[{"name":"jCastlight Health, San Francisco, California"},{"name":"kCenter for Primary Care & Outcomes Research, and Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Weintraub","sequence":"additional","affiliation":[{"name":"dGlobal Health and Social Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"lAriadne Laboratories, Boston, Massachusetts"},{"name":"mDivision of Global Health Equity, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Whaley","sequence":"additional","affiliation":[{"name":"gDepartment of Anesthesiology, Critical Care, and Pain Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"nBrown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Brownstein","sequence":"additional","affiliation":[{"name":"cPediatrics"},{"name":"fComputational Epidemiology Laboratory, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"9","key":"2024080102524425800_B1","doi-asserted-by":"crossref","first-page":"e2019933","DOI":"10.1001\/jamanetworkopen.2020.19933","article-title":"Racism, not race, drives inequity across the COVID-19 continuum","volume":"3","author":"Khazanchi","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2024080102524425800_B2","doi-asserted-by":"crossref","first-page":"e2036462","DOI":"10.1001\/jamanetworkopen.2020.36462","article-title":"Association of social and demographic factors with COVID-19 incidence and death rates in the United States","volume":"4","author":"Karmakar","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2024080102524425800_B3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jamapediatrics.2021.1682","article-title":"Pediatric COVID-19 disparities and prioritizing equity-children are not spared","volume":"175","author":"Dennis-Heyward","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"9","key":"2024080102524425800_B4","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1007\/s11606-020-05882-3","article-title":"County-level association of social vulnerability with COVID-19 cases and deaths in the United States","volume":"35","author":"Khazanchi","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"7","key":"2024080102524425800_B5","doi-asserted-by":"crossref","first-page":"taaa076","DOI":"10.1093\/jtm\/taaa076","article-title":"Geographic access to United States SARS-CoV-2 testing sites highlights health care disparities and may bias transmission estimates","volume":"27","author":"Rader","year":"2020","journal-title":"J Travel Med"},{"issue":"13","key":"2024080102524425800_B6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15585\/mmwr.mm7113e1","article-title":"Use of at-home COVID-19 tests\u2013United States, August 23, 2021\u2013March 12, 2022","volume":"71","author":"Rader","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2024080102524425800_B7","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1007\/s11606-021-07081-0","article-title":"Inequities in the geographic accessibility of COVID-19 biomedical therapeutic trials in the United States","volume":"36","author":"Khazanchi","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"11","key":"2024080102524425800_B8","doi-asserted-by":"crossref","first-page":"e2241144","DOI":"10.1001\/jamanetworkopen.2022.41144","article-title":"Geographic accessibility of COVID-19 test to treat sites by race, ethnicity, age, and rurality","volume":"5","author":"Khazanchi","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2024080102524425800_B9","doi-asserted-by":"crossref","first-page":"e220050","DOI":"10.1001\/jamahealthforum.2022.0050","article-title":"Strategies to promote equity in COVID-19 antiviral treatment","volume":"3","author":"Fiscella","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"10","key":"2024080102524425800_B10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.2022.1243","article-title":"Anti-SARS-CoV-2 monoclonal antibody distribution to high-risk Medicare beneficiaries, 2020\u20132021","volume":"327","author":"Behr","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"2024080102524425800_B11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s43856-022-00183-8","article-title":"Spatial modeling of vaccine deserts as barriers to controlling SARS-CoV-2","volume":"2","author":"Rader","year":"2022","journal-title":"Commun Med (Lond)"},{"issue":"3","key":"2024080102524425800_B12","doi-asserted-by":"crossref","first-page":"e210434","DOI":"10.1001\/jamahealthforum.2021.0434","article-title":"Vaccine hesitancy is a scapegoat for structural racism","volume":"2","author":"Corbie-Smith","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"9","key":"2024080102524425800_B13","doi-asserted-by":"crossref","first-page":"e212666","DOI":"10.1001\/jamahealthforum.2021.2666","article-title":"Disparities in SARS-CoV-2 vaccination-to-infection risk during the COVID-19 pandemic in Massachusetts","volume":"2","author":"Dryden-Peterson","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"9","key":"2024080102524425800_B14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/jamapediatrics.2021.1685","article-title":"Association between race and COVID-19 outcomes among 2.6 million children in England","volume":"175","author":"Saatci","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"11","key":"2024080102524425800_B15","doi-asserted-by":"crossref","first-page":"e2030280","DOI":"10.1001\/jamanetworkopen.2020.30280","article-title":"Race\/ethnicity among children with COVID-19\u2013associated multisystem inflammatory syndrome","volume":"3","author":"Lee","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2024080102524425800_B16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"2024080102524425800_B17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2352-4642(21)00050-X","article-title":"Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the United States: a retrospective surveillance study","volume":"5","author":"Abrams","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"2024080102524425800_B18","unstructured":"Artiga\u2008S, Hill\u2008L, Ndugga\u2008N. KFF. Racial disparities in COVID-19 impacts and vaccinations for children. Available at: https:\/\/www.kff.org\/racial-equity-and-health-policy\/issue-brief\/racial-disparities-in-covid-19-impacts-and-vaccinations-for-children\/. Accessed August 24, 2022"},{"issue":"6","key":"2024080102524425800_B19","doi-asserted-by":"crossref","first-page":"e2021053760","DOI":"10.1542\/peds.2021-053760","article-title":"COVID-19\u2013associated orphanhood and\u00a0caregiver death in the United\u00a0States","volume":"148","author":"Hillis","year":"2021","journal-title":"Pediatrics"},{"key":"2024080102524425800_B20","unstructured":"Office of the Commissioner; US Food and Drug Administration. Comirnaty and Pfizer-BioNTech COVID-19 vaccine. Available at: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/comirnaty-and-pfizer-biontech-covid-19-vaccine. Accessed August 24, 2022"},{"key":"2024080102524425800_B21","unstructured":"Office of the Commissioner; US Food and Drug Administration. Spikevax and Moderna COVID-19 vaccine. Available at: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/spikevax-and-moderna-covid-19-vaccine. Accessed August 24, 2022"},{"issue":"5","key":"2024080102524425800_B22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3201\/eid2805.220166","article-title":"Disparities in first-dose COVID-19 vaccination coverage among children 5\u201311 years of age, United States","volume":"28","author":"Murthy","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2024080102524425800_B23","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1186\/s12889-021-11725-5","article-title":"Parental COVID-19 vaccine hesitancy for children: vulnerability in an urban hotspot","volume":"21","author":"Alfieri","year":"2021","journal-title":"BMC Public Health"},{"issue":"1","key":"2024080102524425800_B24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/vaccines10010031","article-title":"COVID-19 pediatric vaccine hesitancy among racially diverse parents in the United States","volume":"10","author":"Fisher","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"2024080102524425800_B25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.15585\/mmwr.mm7109a2","article-title":"Disparities in COVID-19 vaccination coverage between urban and rural counties\u2013United States, December 14, 2020\u2013January 31, 2022","volume":"71","author":"Saelee","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2024080102524425800_B26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-129-5-199809010-00012","article-title":"Access to care is the centerpiece in the elimination of socioeconomic disparities in health","volume":"129","author":"Andrulis","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"2024080102524425800_B27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/002214650504600103","article-title":"Neighborhood socioeconomic disadvantage and access to health care","volume":"46","author":"Kirby","year":"2005","journal-title":"J Health Soc Behav"},{"issue":"6","key":"2024080102524425800_B28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","article-title":"Exposing some important barriers to health care access in the rural United States","volume":"129","author":"Douthit","year":"2015","journal-title":"Public Health"},{"issue":"2","key":"2024080102524425800_B29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.japh.2016.12.065","article-title":"Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities","volume":"57","author":"Qato","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"2024080102524425800_B30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jnci\/92.3.269","article-title":"Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery","volume":"92","author":"Athas","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2024080102524425800_B31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/irv.12227","article-title":"Clinic accessibility and clinic-level predictors of the geographic variation in 2009 pandemic influenza vaccine coverage in Montreal, Canada","volume":"8","author":"Charland","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"2024080102524425800_B32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1542\/peds.2009-0233","article-title":"Spatial accessibility to providers and vaccination compliance among children with Medicaid","volume":"124","author":"Fu","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2024080102524425800_B33","doi-asserted-by":"crossref","first-page":"taac018","DOI":"10.1093\/jtm\/taac018","article-title":"Assessment of geographic access to monoclonal antibodies in the United States","volume":"29","author":"Rader","year":"2022","journal-title":"J Travel Med"},{"issue":"4","key":"2024080102524425800_B34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2105\/AJPH.2022.307198","article-title":"Identifying COVID-19 vaccine deserts and ways to reduce them: a digital tool to support public health decision-making","volume":"113","author":"Weintraub","year":"2023","journal-title":"Am J Public Health"},{"issue":"4","key":"2024080102524425800_B35","doi-asserted-by":"crossref","first-page":"100583","DOI":"10.1016\/j.hjdsi.2021.100583","article-title":"Association of social vulnerability, COVID-19 vaccine site density, and vaccination rates in the United States","volume":"9","author":"Thakore","year":"2021","journal-title":"Healthc (Amst)"},{"issue":"19","key":"2024080102524425800_B36","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine"},{"key":"2024080102524425800_B37","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/jpids\/piac091","article-title":"Pediatric COVID-19 health disparities and vaccine equity","volume":"11","author":"Oliveira","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"5","key":"2024080102524425800_B38","doi-asserted-by":"crossref","first-page":"e2111629","DOI":"10.1001\/jamanetworkopen.2021.11629","article-title":"Factors associated with racial\/ethnic group-based medical mistrust and perspectives on COVID-19 vaccine trial participation and vaccine uptake in the United States","volume":"4","author":"Thompson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2024080102524425800_B39","unstructured":"CDC. VTrckS: Vaccine Tracking System. Available at: https:\/\/www.cdc.gov\/vaccines\/programs\/vtrcks\/index.html. Accessed March 20, 2023"},{"issue":"3","key":"2024080102524425800_B40","doi-asserted-by":"crossref","first-page":"e20191207","DOI":"10.1542\/peds.2019-1207","article-title":"Pediatricians\u2019 experiences with and perceptions of the vaccines for children program","volume":"145","author":"O\u2019Leary","year":"2020","journal-title":"Pediatrics"},{"issue":"27","key":"2024080102524425800_B41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15585\/mmwr.mm6927a2","article-title":"Provision of pediatric immunization services during the COVID-19 pandemic: an assessment of capacity among pediatric immunization providers participating in the Vaccines for Children Program\u2013United States, May 2020","volume":"69","author":"Vogt","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2024080102524425800_B42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.15585\/mmwr.mm7110a4","article-title":"COVID-19 vaccine provider access and vaccination coverage among children aged 5\u201311 years\u2013United States, November 2021\u2013January 2022","volume":"71","author":"Kim","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2024080102524425800_B43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/00333549231186606","article-title":"The US Federal Retail Pharmacy Program: optimizing COVID-19 vaccine delivery through a strategic public\u2013private partnership","volume":"138","author":"Kim","year":"2023","journal-title":"Public Health Rep"},{"key":"2024080102524425800_B44","unstructured":"Center for Drug Evaluation and Research; US Food and Drug Administration. National Drug Code database background information. Available at: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/national-drug-code-database-background-information. Accessed December 28, 2023"},{"key":"2024080102524425800_B45","doi-asserted-by":"crossref","unstructured":"Brownstein\u2008J, Cantor\u2008JH, Rader\u2008B, Simon\u2008KI, Whaley\u2008CM. National Bureau of Economic Research. If you build it, will they vaccinate? The impact of COVID-19 vaccine sites on vaccination rates and outcomes. Available at: https:\/\/www.nber.org\/papers\/w30429. Accessed December 25, 2023","DOI":"10.3386\/w30429"},{"key":"2024080102524425800_B46","unstructured":"U.S. Census Bureau. American Community Survey 2017\u20132021 5-year data release. Available at: https:\/\/www.census.gov\/newsroom\/press-kits\/2022\/acs-5-year.html. Accessed March 24, 2023"},{"key":"2024080102524425800_B47","unstructured":"U.S. Department of Agriculture Economic Research Service. Rural\u2013Urban Commuting Area (RUCA) codes. Available at: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/. Accessed August 24, 2022"},{"issue":"2","key":"2024080102524425800_B48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamainternmed.2014.6300","article-title":"Geographic accessibility to clinical trials for advanced cancer in the United States","volume":"175","author":"Galsky","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"7688","key":"2024080102524425800_B49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature25181","article-title":"A global map of travel time to cities to assess inequalities in accessibility in 2015","volume":"553","author":"Weiss","year":"2018","journal-title":"Nature"},{"issue":"1","key":"2024080102524425800_B50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12916-019-1459-6","article-title":"Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and response","volume":"17","author":"Hulland","year":"2019","journal-title":"BMC Med"},{"issue":"1","key":"2024080102524425800_B51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01386390","article-title":"A note on two problems in connexion with graphs","volume":"1","author":"Dijkstra","year":"1959","journal-title":"Numer Math"},{"key":"2024080102524425800_B52","unstructured":"Federal Register. Update to access standards drive time calculations. Available at: https:\/\/www.federalregister.gov\/documents\/2020\/07\/15\/2020-14341\/update-to-access-standards-drive-time-calculations. Accessed May 1, 2024"},{"key":"2024080102524425800_B53","unstructured":"National Center for Health Statistics; CDC. US Census populations with bridged race categories. Available at: https:\/\/www.cdc.gov\/nchs\/nvss\/bridged_race.htm. Accessed April 19, 2023"},{"issue":"26","key":"2024080102524425800_B54","doi-asserted-by":"crossref","first-page":"847","DOI":"10.15585\/mmwr.mm7126a3","article-title":"COVID-19 vaccine provider availability and vaccination coverage among children aged 5\u201311 Years\u2013United States, November 1, 2021\u2013April 25, 2022","volume":"71","author":"DeCuir","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2024080102524425800_B55","doi-asserted-by":"crossref","first-page":"e214501","DOI":"10.1001\/jamahealthforum.2021.4501","article-title":"Disadvantage indices deployed to promote equitable allocation of COVID-19 vaccines in the United States: a scoping review of differences and similarities in design","volume":"3","author":"Srivastava","year":"2022","journal-title":"JAMA Health Forum"},{"key":"2024080102524425800_B56","unstructured":"CDC. CDC\u2019s Social Vulnerability Index. Available at: https:\/\/svi.cdc.gov\/. Accessed April 2, 2020"},{"key":"2024080102524425800_B57","unstructured":"US Department of Agriculture Economic Research Service. 2013 Rural\u2013Urban Continuum codes. Available at: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes.aspx. Accessed February 21, 2021"},{"issue":"11","key":"2024080102524425800_B58","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1890\/07-0043.1","article-title":"Quasi-Poisson versus negative binomial regression: how should we model overdispersed count data?","volume":"88","author":"Ver Hoef","year":"2007","journal-title":"Ecology"},{"issue":"7","key":"2024080102524425800_B59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.15585\/mmwr.mm7207a4","article-title":"COVID-19 vaccination coverage and demographic characteristics of infants and children aged 6 months\u20134 years\u2013United States, June 20\u2013December 31, 2022","volume":"72","author":"Murthy","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2024080102524425800_B60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1377\/hlthaff.2017.1104","article-title":"Diffusion of innovations theory, principles, and practice","volume":"37","author":"Dearing","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"2024080102524425800_B61","doi-asserted-by":"crossref","first-page":"e2021052335","DOI":"10.1542\/peds.2021-052335","article-title":"Parents\u2019 intentions and perceptions about COVID-19 vaccination for their\u2009children: results from a national survey","volume":"148","author":"Szilagyi","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"2024080102524425800_B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7201a1","article-title":"Racial and ethnic differences in COVID-19 vaccination coverage among children and adolescents aged 5\u201317 years and parental intent to vaccinate their children\u2013National Immunization Survey\u2013Child COVID Module, United States, December 2020\u2013September 2022","volume":"72","author":"Valier","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024080102524425800_B63","unstructured":"Goodnough\u2008A, Hoffman\u2008J. The New York Times. The wealthy are getting more vaccinations, even in poorer neighborhoods. Available at: https:\/\/www.nytimes.com\/2021\/02\/02\/health\/white-people-covid-vaccines-minorities.html. Accessed April 19, 2023"},{"issue":"46","key":"2024080102524425800_B64","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.15585\/mmwr.mm7146a3","article-title":"Sociodemographic variation in early uptake of COVID-19 vaccine and parental intent and attitudes toward vaccination of children aged 6 months\u20134 years\u2013United States, July 1\u201329, 2022","volume":"71","author":"Santibanez","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2024080102524425800_B65","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamapediatrics.2023.3260","article-title":"Cost-related barriers and ensuring equitable access to vaccines in the United States","volume":"177","author":"Essien","year":"2023","journal-title":"JAMA Pediatr"},{"key":"2024080102524425800_B66","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.acap.2021.01.017","article-title":"What works to increase vaccination uptake","volume":"21","author":"Brewer","year":"2021","journal-title":"Acad Pediatr"},{"issue":"35","key":"2024080102524425800_B67","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.15585\/mmwr.mm7135a2","article-title":"Parental intentions and perceptions toward COVID-19 vaccination among children aged 4 months to 4 years\u2013PROTECT cohort, four states, July 2021\u2013May 2022","volume":"71","author":"Lutrick","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2024080102524425800_B68","doi-asserted-by":"crossref","first-page":"e210213","DOI":"10.1001\/jamahealthforum.2021.0213","article-title":"Taking vaccine to where the virus is\u2013equity and effectiveness in coronavirus vaccinations","volume":"2","author":"Bibbins-Domingo","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"6","key":"2024080102524425800_B69","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1016\/S2214-109X(21)00099-1","article-title":"A 3-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community","volume":"9","author":"Abdul-Mutakabbir","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"9","key":"2024080102524425800_B70","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late\u2013preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"key":"2024080102524425800_B71","unstructured":"Office of the Commissioner; US Food and Drug Administration. FDA approves new drug to prevent RSV in infants and toddlers. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-prevent-rsv-babies-and-toddlers. Accessed August 5, 2023"},{"key":"2024080102524425800_B72","volume-title":"Framework for Equitable Allocation of COVID-19 Vaccine","author":"National Academies of Sciences, Engineering, and Medicine","year":"2020"},{"issue":"15","key":"2024080102524425800_B73","first-page":"2200302","article-title":"Innovations in public health surveillance: updates from a forum convened by the WHO Hub for Pandemic and Epidemic Intelligence, February 2\u20133 2022","volume":"27","author":"Morgan","year":"2022","journal-title":"Euro Surveill"},{"issue":"12","key":"2024080102524425800_B74","doi-asserted-by":"crossref","first-page":"e2247957","DOI":"10.1001\/jamanetworkopen.2022.47957","article-title":"Associations of neighborhood opportunity and social vulnerability with trajectories of childhood body mass index and obesity among US children","volume":"5","author":"Aris","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024080102524425800_B75","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1182\/blood-2019-125351","article-title":"Social vulnerability is associated with emergency department dependency in pediatric sickle cell disease patients","volume":"134","author":"Lai","year":"2019","journal-title":"Blood"},{"key":"2024080102524425800_B76","doi-asserted-by":"crossref","first-page":"736195","DOI":"10.3389\/fcomm.2021.736195","article-title":"Methodological considerations for survey-based research during emergencies and public health crises: improving the quality of evidence and communication","volume":"6","author":"Kennedy","year":"2022","journal-title":"Front Commun (Lausanne)"},{"key":"2024080102524425800_B77","unstructured":"Maybank\u2008A\n          . The New York Times. The pandemic\u2019s missing data. Available at: https:\/\/www.nytimes.com\/2020\/04\/07\/opinion\/coronavirus-blacks.html. Accessed July 12, 2020"},{"key":"2024080102524425800_B78","unstructured":"Krieger\u2008N, Gonsalves\u2008G, Bassett\u2008MT, Hanage\u2008W, Krumholz\u2008HM. Health Affairs Forefront. The fierce urgency of now: closing glaring gaps in us surveillance data on COVID-19. Available at: https:\/\/www.healthaffairs.org\/content\/forefront\/fierce-urgency-now-closing-glaring-gaps-us-surveillance-data-covid-19. Accessed December 15, 2023"},{"key":"2024080102524425800_B79","doi-asserted-by":"crossref","first-page":"m3795","DOI":"10.1136\/bmj.m3795","article-title":"COVID-19: how to prioritize worse-off populations in allocating safe and effective vaccines","volume":"371","author":"Schmidt","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"2024080102524425800_B80","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1097\/PHH.0000000000001844","article-title":"Achieving equity in childhood vaccination: a mixed-methods study of immunization programs, policies, and coverage in 3 US States","volume":"30","author":"Brumbaugh","year":"2024","journal-title":"J Public Health Manag Pract"},{"issue":"2","key":"2024080102524425800_B81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/00333549211061317","article-title":"Minnesota electronic health record consortium COVID-19 project: informing pandemic response through statewide collaboration using observational data","volume":"137","author":"Winkelman","year":"2022","journal-title":"Public Health Rep"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-065938\/1685337\/peds.2024-065938.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-065938\/1685337\/peds.2024-065938.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T03:00:47Z","timestamp":1722481247000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/154\/2\/e2024065938\/197802\/Spatial-Accessibility-and-Uptake-of-Pediatric"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":81,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,7,19]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2024-065938","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"e2024065938"}}